This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stone, D.
Right arrow Articles by Lieber, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stone, D.
Right arrow Articles by Lieber, A.
Right arrowPubmed/NCBI databases
*Gene*Genome
*Protein

 Previous Article  |  Next Article 

Journal of Virology, April 2005, p. 5090-5104, Vol. 79, No. 8
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.8.5090-5104.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Development and Assessment of Human Adenovirus Type 11 as a Gene Transfer Vector

Daniel Stone,1 Shaoheng Ni,1 Zong-Yi Li,1 Anuj Gaggar,1,2 Nelson DiPaolo,1 Qinghua Feng,2 Volker Sandig,3 and André Lieber1,2*

Division of Medical Genetics, Department of Medicine,1 Department of Pathology, University of Washington, Seattle, Washington,2 ProBiogen AG, Berlin, Germany3

Received 12 October 2004/ Accepted 3 December 2004

Adenovirus vectors based on human serotype 5 (Ad5) have successfully been used as gene transfer vectors in many gene therapy-based approaches to treat disease. Despite their widespread application, many potential therapeutic applications are limited by the widespread prevalence of vector-neutralizing antibodies within the human population and the inability of Ad5-based vectors to transduce important therapeutic target cell types. In an attempt to circumvent these problems, we have developed Ad vectors based on human Ad serotype 11 (Ad11), since the prevalence of neutralizing antibodies to Ad11 in humans is low. E1-deleted Ad11 vector genomes were generated by homologous recombination in 293 cells expressing the Ad11-E1B55K protein or by recombination in Escherichia coli. E1-deleted Ad11 genomes did not display transforming activity in rodent cells. Transduction of primary human CD34+ hematopoietic progenitor cells and immature dendritic cells was more efficient with Ad11 vectors than with Ad5 vectors. Thirty minutes after intravenous injection into mice that express one of the Ad11 receptors (CD46), we found, in a pattern and at a level comparable to what is found in humans, Ad11 vector genomes in all analyzed organs, with the highest amounts in liver, lung, kidney, and spleen. Neither Ad11 genomes nor Ad11 vector-mediated transgene expression were, however, detected at 72 h postinfusion. A large number of Ad11 particles were also found to be associated with circulating blood cells. We also discovered differences in in vitro transduction efficiencies and in vivo biodistributions between Ad11 vectors and chimeric Ad5 vectors possessing Ad11 fibers, indicating that Ad11 capsid proteins other than fibers influence viral infectivity and tropism. Overall, our study provides a basis for the application of Ad11 vectors for in vitro and in vivo gene transfer and for gaining an understanding of the factors that determine Ad tropism.

* Corresponding author. Mailing address: University of Washington, Division of Medical Genetics, Box 357720, Seattle, WA 98195. Phone: (206) 221-3973. Fax: (206) 685-8675. E-mail: lieber00{at}u.washington.edu.

Journal of Virology, April 2005, p. 5090-5104, Vol. 79, No. 8
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.8.5090-5104.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Hassan, M.H., Khatoon, N., Curiel, D.T., Hamada, F.M., Arafa, H.M., Al-Hendy, A. (2008). Toward gene therapy of uterine fibroids: targeting modified adenovirus to human leiomyoma cells. Hum Reprod 23: 514-524 [Abstract] [Full Text]  
  • Onion, D., Crompton, L. J., Milligan, D. W., Moss, P. A. H., Lee, S. P., Mautner, V. (2007). The CD4+ T-cell response to adenovirus is focused against conserved residues within the hexon protein. J. Gen. Virol. 88: 2417-2425 [Abstract] [Full Text]  
  • Stone, D., Liu, Y., Shayakhmetov, D., Li, Z.-Y., Ni, S., Lieber, A. (2007). Adenovirus-Platelet Interaction in Blood Causes Virus Sequestration to the Reticuloendothelial System of the Liver. J. Virol. 81: 4866-4871 [Abstract] [Full Text]  
  • Johansson, C., Jonsson, M., Marttila, M., Persson, D., Fan, X.-L., Skog, J., Frangsmyr, L., Wadell, G., Arnberg, N. (2007). Adenoviruses Use Lactoferrin as a Bridge for CAR-Independent Binding to and Infection of Epithelial Cells. J. Virol. 81: 954-963 [Abstract] [Full Text]  
  • Tuve, S., Wang, H., Ware, C., Liu, Y., Gaggar, A., Bernt, K., Shayakhmetov, D., Li, Z., Strauss, R., Stone, D., Lieber, A. (2006). A New Group B Adenovirus Receptor Is Expressed at High Levels on Human Stem and Tumor Cells. J. Virol. 80: 12109-12120 [Abstract] [Full Text]  
  • Ruzsics, Z., Wagner, M., Osterlehner, A., Cook, J., Koszinowski, U., Burgert, H.-G. (2006). Transposon-assisted cloning and traceless mutagenesis of adenoviruses: development of a novel vector based on species d.. J. Virol. 80: 8100-8113 [Abstract] [Full Text]  
  • Al-Hendy, A., Salama, S. (2006). Gene therapy and uterine leiomyoma: a review. Hum Reprod Update 12: 385-400 [Abstract] [Full Text]  
  • Gustafsson, D. J., Segerman, A., Lindman, K., Mei, Y.-F., Wadell, G. (2006). The Arg279Glu Substitution in the Adenovirus Type 11p (Ad11p) Fiber Knob Abolishes EDTA-Resistant Binding to A549 and CHO-CD46 Cells, Converting the Phenotype to That of Ad7p. J. Virol. 80: 1897-1905 [Abstract] [Full Text]  
  • Verhaagh, S., de Jong, E., Goudsmit, J., Lecollinet, S., Gillissen, G., de Vries, M., van Leuven, K., Que, I., Ouwehand, K., Mintardjo, R., Weverling, G. J., Radosevic, K., Richardson, J., Eloit, M., Lowik, C., Quax, P., Havenga, M. (2006). Human CD46-transgenic mice in studies involving replication-incompetent adenoviral type 35 vectors. J. Gen. Virol. 87: 255-265 [Abstract] [Full Text]  
  • Yang, T.-C., Millar, J., Groves, T., Grinshtein, N., Parsons, R., Takenaka, S., Wan, Y., Bramson, J. L. (2006). The CD8+ T Cell Population Elicited by Recombinant Adenovirus Displays a Novel Partially Exhausted Phenotype Associated with Prolonged Antigen Presentation That Nonetheless Provides Long-Term Immunity. J. Immunol. 176: 200-210 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»